RxDoctor Payments DataLook up a doctor →

Kavita Kalidas, MD

Neurology · Lutz, FLNPI 1831388867

Payments from drug & device makers

$2,054,776in general payments, 2019–2025

Across 1,548 payments — averaging $1327.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1M
  • Eli Lilly$470K
  • Amgen$238K
  • Lilly USA, LLC$83K
  • Lundbeck LLC$56K
  • H. Lundbeck A S$52K
  • plus $147K from 30 others
$43,487in research payments, 2019–2025

Across 12 payments — averaging $3623.91 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$42K
  • Amgen$1K

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)691$1,008,485
Eli Lilly78$470,097
Amgen205$237,973
Lilly USA, LLC210$82,577
Lundbeck LLC105$56,275
H. Lundbeck A S26$52,191
Biogen1$25,000
Axsome Therapeutics, Inc.21$24,044
Upsher-smith Laboratories LLC9$22,470
Biohaven Pharmaceuticals, Inc.31$19,799
Impel Pharmaceuticals Inc.18$18,114
Pfizer42$11,441
Biohaven Pharmaceutical Holding Company Ltd.12$11,394
Teva Pharmaceuticals USA, Inc.29$10,965
Novartis11$2,223
Acadia Pharmaceuticals Inc6$322
EMD Serono, Inc.7$280
Tonix Medicines, Inc.6$183
Scilex Pharmaceuticals Inc.8$168
Argenx US, Inc.4$163
Impel Pharmaceuticals LLC7$152
Merz Pharmaceuticals, LLC4$78
Otsuka America Pharmaceutical, Inc.1$57
TG Therapeutics, Inc.3$56
SK Life Science, Inc.2$54
Assertio Therapeutics, Inc.1$27
Atland Pharmaceuticals, LLC1$25
Azurity Pharmaceuticals, Inc.1$23
Mallinckrodt Hospital Products Inc.1$22
Genentech USA, Inc.1$20
Johnson & Johnson1$18
Catalyst Pharmaceuticals, Inc.1$17
UCB, Inc.1$16
Cycle Pharmaceuticals Inc1$16
C2n Diagnostics, LLC1$16
Amneal Pharmaceuticals LLC1$15

How this compares

$2,054,776 in reported general payments places this provider in the 95th percentile of 1,434 neurology providers in Florida.

See all neurology providers in Florida →

Medicare billing

Part B allowed, 2024
$10,677
Medicare patients
29
Services billed
449

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other neurology in Lutz

See the full list for Florida →

Where these figures come from

Is this you, or does something look wrong? →